Status
Conditions
Treatments
About
Technical advances in lenses are continuous and materials are improved. We provide a prospective longitudinal observational study evaluating the efficacy and safety of new EyeBrid Excel hybrid lenses (LCS) in the treatment of severe ametropia and for patients with corneal irregularities.
This study should include 60 patients for a period of three months. The aim of this work is to assess the improvement in the best corrected visual acuity and the good tolerance of this lens.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
o Wear rigid lenses and complain about their lenses (discomfort, loss, poor vision) or
Any patient diagnosed with Keratoconus stages 1 to 3.
Be affiliated to the social security system
Exclusion criteria
60 participants in 1 patient group
Loading...
Central trial contact
Jean-Claude Quintyn, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal